Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-10 9:02 pm Purchase |
2025-02-05 | 13G | BriaCell Therapeutics Corp. BCTX |
3i, LP | 369,000 9.900% |
369,000 (New Position) |
Filing History |
| 2024-12-12 06:06 am Purchase |
2024-12-10 | 13D | BriaCell Therapeutics Corp. BCTX |
L5 Capital Inc. | 268,758 10.700% |
5,167 (+1.96%) |
Filing History |
| 2024-12-10 06:06 am Purchase |
2024-12-06 | 13D | BriaCell Therapeutics Corp. BCTX |
L5 Capital Inc. | 263,591 10.500% |
7,667 (+3.00%) |
Filing History |
| 2024-12-05 07:45 am Purchase |
2024-12-03 | 13D | BriaCell Therapeutics Corp. BCTX |
L5 Capital Inc. | 255,925 10.000% |
75,729 (+42.03%) |
Filing History |
| 2024-11-14 12:17 pm Sale |
2024-09-30 | 13G | BriaCell Therapeutics Corp. BCTX |
CVI Investments, Inc. | 40,000 1.900% |
-133,913 (-77.00%) |
Filing History |
| 2024-09-16 10:22 am Purchase |
2024-09-11 | 13G | BriaCell Therapeutics Corp. BCTX |
CVI Investments, Inc. | 173,913 8.500% |
173,913 (New Position) |
Filing History |
| 2024-05-24 08:58 am Purchase |
2024-05-14 | 13D | BriaCell Therapeutics Corp. BCTX |
L5 Capital Inc. | 180,196 14.700% |
78,196 (+76.66%) |
Filing History |
| 2024-01-08 11:01 am Purchase |
2023-12-29 | 13G | BriaCell Therapeutics Corp. BCTX |
Copia Fund (Cayman) LP | 54,558 5.100% |
54,558 (New Position) |
Filing History |
| 2023-02-14 4:35 pm Purchase |
2022-12-31 | 13G | BriaCell Therapeutics Corp. BCTX |
Lynwood Capital Management Inc. | 97,333 9.300% |
39,333 (+67.82%) |
Filing History |
| 2022-08-01 07:00 am Purchase |
2022-07-20 | 13G | BriaCell Therapeutics Corp. BCTX |
Lynwood Capital Management Inc. | 58,000 5.600% |
5,667 (+10.83%) |
Filing History |
| 2022-04-25 4:05 pm Purchase |
2022-04-14 | 13G | BriaCell Therapeutics Corp. BCTX |
Southwest Private Capital Inc. | 52,134 5.100% |
52,134 (New Position) |
Filing History |
| 2022-02-14 3:21 pm Unchanged |
2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX |
CVI Investments, Inc. | 40,000 3.600% |
0 (Unchanged) |
Filing History |
| 2022-02-11 8:39 pm Purchase |
2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX |
Altium Capital Management LLC | 60,000 4.700% |
26,667 (+80.00%) |
Filing History |
| 2022-02-11 5:47 pm Sale |
2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX |
L1 Capital Global Opportunities Master Fund, Ltd. | 7,000 11.000% |
-59,667 (-89.50%) |
Filing History |
| 2022-02-11 5:01 pm Sale |
2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX |
Lind Global Macro Fund LP | 2,443 0.200% |
-35,063 (-93.49%) |
Filing History |
| 2022-02-11 08:00 am Sale |
2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX |
Lynwood Capital Management Inc. | 52,333 4.920% |
-6,333 (-10.80%) |
Filing History |
| 2022-02-04 4:35 pm Sale |
2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX |
BIGGER CAPITAL FUND L P | 10,000 11.000% |
-139,000 (-93.29%) |
Filing History |
| 2022-01-20 09:47 am Sale |
2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX |
Empery Asset Management, LP | 33,333 2.520% |
-760 (-2.23%) |
Filing History |
| 2022-01-03 7:24 pm Purchase |
2021-12-31 | 13G | BriaCell Therapeutics Corp. BCTX |
SABBY MANAGEMENT LLC | 50,459 11.000% |
13,459 (+36.38%) |
Filing History |
| 2021-09-20 5:25 pm Sale |
2021-09-16 | 13D | BriaCell Therapeutics Corp. BCTX |
Hyperscale Data Inc. GPUS |
47,667 4.670% |
-11,333 (-19.21%) |
Filing History |